Nigeria: Nation Faces Major Challenge to Vaccinating Children
[allAfrica] As we look back on the public health issues that caught the world's attention in 2015, immunization stands out. Whether it was the measles outbreak in the US or the Ebola vaccine trials in Guinea, vaccines were top of mind throughout the year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 13, 2016 Category: African Health Source Type: news

Africa: Ebola, Malaria Vaccines - HIV Treatments Expected in 2016
[East African] Major breakthroughs in the development of vaccines for major diseases including malaria and HIV/Aids are expected this year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 11, 2016 Category: African Health Source Type: news

Walter Reed Army Institute of Research begins phase 2 clinical trial of Ebola vaccine
(The U.S. Military HIV Research Program (MHRP)) The Walter Reed Army Institute of Research (WRAIR) today began a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 6, 2016 Category: Infectious Diseases Source Type: news

Research and Development: diagnostics, vaccines and therapies
Publications and documents on Ebola vaccines (Source: WHO news on Ebola)
Source: WHO news on Ebola - January 3, 2016 Category: Infectious Diseases Tags: ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola Source Type: news

Behind the Headlines' Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications.Researchers collected white blood cells from African and Asian elephants. They found that elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene.Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news

Behind the Headlines Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications. Researchers collected white blood cells from African and Asian elephants. They found elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene. Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we do...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news

World Health Organization to Review Merck’s Investigational Ebola Vaccine for Emergency Use Assessment and Listing
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the application for Emergency Use Assessment and Listing (EUAL) for the company’s investigational Ebola Zaire vaccine, V920 (rVSV∆G-ZEBOV-GP, live attenuated), has been accepted for review by the World Health Organization (WHO). Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Skip Irvine, 215-652-6059orInvestors:Teri Loxa...
Source: Merck.com - Corporate News - December 23, 2015 Category: Pharmaceuticals Tags: Vaccine News Corporate News Latest News #Merck #MRK Ebola MSD NYSE:MRK Source Type: news

Your State Likely Can't Handle An Infectious Disease Outbreak
(function(){var src_url="https://spshared.5min.com/Scripts/PlayerSeed.js?playList=519101018&height=&width=100&sid=577&origin=SOLR&videoGroupID=155847&relatedNumOfResults=100&responsive=true&ratio=wide&align=center&relatedMode=2&relatedBottomHeight=60&companionPos=&hasCompanion=false&autoStart=false&colorPallet=%23FFEB00&videoControlDisplayColor=%23191919&shuffle=0&isAP=1&pgType=cmsPlugin&pgTypeId=addToPost-top&onVideoDataLoaded=track5min.DL&onTimeUpdate=track5min.TC&onVideoDataLoaded=HPTrack.Vid.DL&onTimeUpdate=HPTrack.Vid....
Source: Healthy Living - The Huffington Post - December 18, 2015 Category: Consumer Health News Source Type: news

Liberia: 100 Ebola Contacts Vaccinated - Liberia Begins Countdown
[FrontPageAfrica] Monrovia -Liberia is currently in its 20th day without a new case of the dealy Ebola virus since the November 19 outbreak of virus from a household in Du-Port Road. Recently, the Ministry of Health and partners released two of the three cases that were discovered in the country. The strains of the three cases of Ebola have not been discovered by health authorities neither by the Health partners, namely the World Health Organization and Center for Disease Control (CDC). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 11, 2015 Category: African Health Source Type: news

West Africa: Ebola Trial Vaccine Investigator Says Public Myth Vanishing
[FrontPageAfrica] The Chief Investigator of the United States and Liberia research on the Ebola vaccine says misconceptions about the study have vanished amongst Liberians. Dr. Stephen Kennedy said clinical trial in Liberia is new which, he says made it difficult to convince Liberians about the relevance of the scientific research on finding Ebola vaccine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 10, 2015 Category: African Health Source Type: news

The Aftermath of Ebola: Are We Any Better Off?The Aftermath of Ebola: Are We Any Better Off?
A dearth of patients has slowed development of safe and effective Ebola vaccines and drugs. Medscape Infectious Diseases (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 8, 2015 Category: Infectious Diseases Tags: Infectious Diseases Expert Column Source Type: news

Liberia: Liberian Medical Professionals Take Protective Ebola Vaccine
[FrontPageAfrica] Monrovia -In an effort to give reassurance that the VSV vaccine is safe and protective, five senior Liberian medical professionals Wednesday took the vaccine at the John. F. Kennedy medical center in Monrovia. The preventive vaccine is being administered by the Liberia-US Clinical Research Partnership, PREVAIL on behalf of the Liberian government in collaboration with the World Health Organization (WHO), the US Centers for Disease Control and Prevention, UNICEF and other partners. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 26, 2015 Category: African Health Source Type: news

How the World Is Improving Children’s Health (And Where We’re Falling Short)
The most important resolution the United Nations ever passed is also the one of the most head-smackingly obvious ones. It’s been in force since Nov. 20, 1959 and in a perfect—or at least better—world, it would not have been necessary at all. It’s the straightforwardly named Declaration of the Rights of the Child, guaranteeing every child on the planet a name and a nationality, the right to “grow old and develop in health,” to be “protected from racial, religious and other forms of discrimination,” and to have, most fundamentally, a happy childhood. So, how’s that going?...
Source: TIME.com: Top Science and Health Stories - November 20, 2015 Category: Consumer Health News Tags: Uncategorized child brides Children Disease global child mortality health polio UNICEF United Nations vaccines wars Source Type: news

New case reported in Liberia which was declared Ebola free in September
A new case of Ebola has been reported in Liberia, which was declared free of the deadly virus in September.Related items from OnMedicaEbola returns to West AfricaEbola UK nurse readmitted for specialist treatmentEbola outbreak is over in Liberia Experimental Ebola vaccine effective on needle stick doctor Second healthcare worker brought back to England to be monitored for Ebola (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 20, 2015 Category: UK Health Source Type: news

Study finds that Ebola vaccine is safe and stimulates strong immune response
(University of Maryland School of Medicine) A clinical trial of a new Ebola vaccine has found that it is well tolerated and stimulates strong immune responses in adults in Mali and in the US, according to a study published in the latest issue of the journal Lancet Infectious Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 18, 2015 Category: Infectious Diseases Source Type: news

Low-income Brits agree to be injected with experimental Ebola vaccine for barely enough money to pay one month's rent
(NaturalNews) It might seem like a death sentence you wouldn't accept for any amount of money, but some lower-income British citizens appear to believe the risk is worth the reward.As reported by the UK's Daily Mail, a medical research lab is searching for Brits who will voluntarily... (Source: NaturalNews.com)
Source: NaturalNews.com - November 13, 2015 Category: Consumer Health News Source Type: news

CanSino’s Ebola Vaccine Manufacturing Facility, Tianjin
Tianjin CanSino Biotechnology (CanSino) began construction of its first-fully integrated Ebola vaccine manufacturing facility at Tianjin Economic-Technological Development Area (TEDA) west zone in China, in October 2015. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 10, 2015 Category: Pharmaceuticals Source Type: news

October's top stories: New cancer drug delivery approach, J&J Ebola trial
UK researchers develop a new method to improve drug delivery in cancer treatment, J&J initiates clinical trial of Janssen's Ebola prime-boost vaccine regimen in Sierra Leone and Bayer begins Phase III trial of riociguat to treat children with PAH. Dr… (Source: Drug Development Technology)
Source: Drug Development Technology - November 5, 2015 Category: Pharmaceuticals Source Type: news

Could self-disseminating vaccines cut off emerging infectious diseases at source?
(University of Plymouth) An expert review identifies state-of-the-art of self-disseminating vaccines as a new and potentially powerful strategy to circumvent diseases such as Ebola at the animal source before their establishment as the next human pandemic (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2015 Category: Global & Universal Source Type: news

Evening Standard ad seeks healthy 18 to 65-year-olds for Ebola trial
Hammersmith Medical Research is holding clinical trials, starting in November, for a study of an Ebola vaccine. It will involve up to 12 short outpatient appointments, over a year, the ad says. (Source: the Mail online | Health)
Source: the Mail online | Health - October 27, 2015 Category: Consumer Health News Source Type: news

Scientists Hope Tracking Winter Flu Will Help Close Pandemic Knowledge Gap
ImageContent(562e45c2e4b0aac0b8fd7c69,562e42a91900002e00b94dab,Image,HectorAssetUrl(562e42a91900002e00b94dab,Some(),Some(jpeg)),ViktorCap via Getty Images,) Anyone who goes down with flu in Europe this winter could be asked to enroll in a randomized clinical trial in which they will either be given a drug, which may or may not work, or standard advice to take bed rest and paracetamol. Those who agree could be helping the world prepare for the next potentially deadly disease pandemic as well as helping scientists who are now desperate to plug gaps in knowledge left by previous missed opportunities. Scientists are largely in...
Source: Science - The Huffington Post - October 26, 2015 Category: Science Source Type: news

Pilot implementation of first malaria vaccine recommended by WHO advisory groups
The World Health Organization’s Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Committee (MPAC) jointly recommended pilot projects to understand how to best use a vaccine that protects against malaria in young children. “This was a historic meeting with two of WHO’s major advisory committees working together to consider current evidence about this vaccine,” said Professor Fred Binka, acting chair of MPAC. “The committees agreed that pilot implementations should be the next step with this vaccine.” (Source: WHO news)
Source: WHO news - October 23, 2015 Category: Global & Universal Tags: ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, immunization [subject], vaccination, immunization [subject], vaccination, m Source Type: news

To Your Health: NLM update: Ebola vaccine's initial success
Listen to the To Your Health: NLM update on Ebola vaccine's initial success. The transcript is also available. A vaccine to prevent Ebola was successful in an initial clinical trial within the West African nation of Guinea, reports a pioneering study and editorial recently published in The Lancet. (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - October 19, 2015 Category: Consumer Health News Source Type: news

Medical College Develops Fully-Equipped Telemedical Drone
The first fully-equipped medical multirotor drone with telemedicine capability is the newest innovation from Dr. Italo Subbarao, an associate dean and associate professor at the William Carey University College of Osteopathic Medicine, and Guy Paul Cooper Jr., a third-year Carey medical student from Wheaton, Illinois. Subbarao and Cooper have been working on the project, called Healthcare Integrated Rescue Operations (HiRO), since 2014. HiRO is a follow-up to the team's previous project, an analysis of the use of Twitter during the February 2013 Hattiesburg tornado and an application of the social network's usefulness to ...
Source: JEMS Special Topics - October 16, 2015 Category: Emergency Medicine Tags: General News Equipment & Gear Technology Source Type: news

Medical College Develops Fully-Equipped Telemedical Drone
The first fully-equipped medical multirotor drone with telemedicine capability is the newest innovation from Dr. Italo Subbarao, an associate dean and associate professor at the William Carey University College of Osteopathic Medicine, and Guy Paul Cooper Jr., a third-year Carey medical student from Wheaton, Illinois. Subbarao and Cooper have been working on the project, called Healthcare Integrated Rescue Operations (HiRO), since 2014. HiRO is a follow-up to the team's previous project, an analysis of the use of Twitter during the February 2013 Hattiesburg tornado and an application of the social network's usefulness t...
Source: JEMS Special Topics - October 16, 2015 Category: Emergency Medicine Tags: News Equipment & Gear Source Type: news

Ebola returns to West Africa
Two new cases confirmed in Guinea after two weeks of no new casesRelated items from OnMedicaSecond healthcare worker brought back to England to be monitored for EbolaExperimental Ebola vaccine effective on needle stick doctor Ebola 'likely to last at least a year'Ebola outbreak is over in Liberia Ebola UK nurse readmitted for specialist treatment (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 16, 2015 Category: UK Health Source Type: news

Ebola Survives In Semen For Much Longer Than We Thought
This study provides further evidence that survivors need continued, substantial support for the next six to 12 months to meet these challenges and to ensure their partners  are not exposed to potential virus." In the study, 93 male Ebola survivors from Freetown, Sierra Leone, provided a semen sample during a range of two to 10 months after their symptoms first began. All of the men who got tested within three months of disease onset had traces of the virus in their semen, while 65 percent of men who were tested between four to six months showed signs of the virus. Finally, 26 percent of men tested between se...
Source: Science - The Huffington Post - October 15, 2015 Category: Science Source Type: news

Chinese firm says plans to 'mass produce' Ebola vaccine
SHANGHAI (Reuters) - A Chinese firm plans to mass produce a military-developed vaccine against Ebola, even as the epidemic which killed more than 11,000 people in West Africa beings to fade. (Source: Reuters: Health)
Source: Reuters: Health - October 14, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

FDA and access to medical countermeasures during public health emergencies
By: Brooke Courtney, J.D., M.P.H. Just weeks after witnessing the fall of the World Trade Center on Sept. 11, 2001, I was a student volunteer in a New York City hospital emergency department when several people arrived saying they had been exposed to anthrax. One had even brought a small plastic bag holding white powder. Around this time, the media was reporting on letters mailed that were laced with white powder confirmed to be Bacillus anthracis, which causes anthrax. At the hospital, we wondered whether we might become exposed to anthrax and how it could be prevented or treated. We quickly escorted the patients who had ...
Source: Mass Device - October 13, 2015 Category: Medical Equipment Authors: MassDevice Tags: Blog FDA Source Type: news

Friends and family of Pauline Cafferkey given the Ebola vaccine
A total of 58 people who have been in close contact with British nurse Pauline Cafferkey are being monitored by health officials after the 39-year-old was diagnosed with Ebola for the second time. (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2015 Category: Consumer Health News Source Type: news

Bavarian Nordic Announces Initiation Of Safety And Immunogenicity Study Of Ebola Vaccine Regimen In Sierra Leone
Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the initiation of a new clinical study of the Ebola prime-boost vaccine regimen that combines Bavarian Nordic's MVA-BN® Filo vaccine with the Ad26.ZEBOV vaccine from Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - October 12, 2015 Category: Pharmaceuticals Source Type: news

Johnson & Johnson initiates Ebola vaccine clinical trial in Sierra Leone
Johnson & Johnson (J&J) has initiated a clinical trial to evaluate the safety and immunogenicity of Janssen's Ebola prime-boost vaccine regimen in Sierra Leone. (Source: Drug Development Technology)
Source: Drug Development Technology - October 12, 2015 Category: Pharmaceuticals Source Type: news

J&J starts vaccine trial in Sierra Leone, even as Ebola fades
(Reuters) - Johnson & Johnson has begun a clinical trial of a two-shot Ebola vaccine in Sierra Leone, underlining its determination to push ahead with development, even as the epidemic fades out in West Africa. (Source: Reuters: Health)
Source: Reuters: Health - October 9, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Ebola UK nurse readmitted for specialist treatment
Scottish nurse flown back to LondonRelated items from OnMedicaGovernment pays tribute to NHS Ebola volunteersEbola 'likely to last at least a year'Second healthcare worker brought back to England to be monitored for EbolaExperimental Ebola vaccine effective on needle stick doctor Ebola outbreak is over in Liberia (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 9, 2015 Category: UK Health Source Type: news

Tufts biophysicist receives NIH New Innovator Award for Ebola research
(Tufts University, Health Sciences Campus) James Munro of Tufts University School of Medicine is a recipient of the 2015 National Institutes of Health Director's New Innovator Award. Munro is using imaging of glycoproteins to investigate how Ebola and related viruses enter host cells. Understanding this process is expected to help develop vaccines for Ebola and related viruses. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 6, 2015 Category: Infectious Diseases Source Type: news

Sierra Leone: 1.4 Million Under-5 Kids to Be Vaccinated Against Polio
[Concord] As the fight to end the Ebola outbreak goes on, the Ministry of Health and Sanitation continues working with UNICEF, WHO and other development partners, to restore trust in the health system and maintain the delivery of basic health services. (Source: AllAfrica News: Polio)
Source: AllAfrica News: Polio - October 5, 2015 Category: Infectious Diseases Source Type: news

Sierra Leone: Beijing Institute of Biotechnology - Vaccine Clinical Trials in Sierra Leone
[Sierra Leone Government] Freetown -A three day Ebola (Ad 5 - EBOV) Vaccine Phase II Clinical Training for Investigators ahead of the vaccine initiation in Sierra Leone has started at the Shangri La Resort conference hall Aberdeen in Freetown. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 2, 2015 Category: African Health Source Type: news

Uganda: Guinea Vaccine Success Spurs Uganda
[East African] An Ebola vaccine, that has proved to be 100 per cent effective in trials in Guinea, is giving hope to scientists conducting similar trials across the continent. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 21, 2015 Category: African Health Source Type: news

Experimental Ebola Vaccine Regimen Takes New Steps under HHS Program
As part of the international effort to develop vaccines that protect against Ebola and similar viruses, the advanced development of an experimental vaccine regimen will take new steps with support from an agreement between the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) and Crucell Holland, B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in the Netherlands. (Source: PHPartners.org)
Source: PHPartners.org - September 18, 2015 Category: Global & Universal Source Type: news

Ebola research shows the value of vaccines
Clinical science is catching up with the West African Ebola outbreak that has killed more than 11,000 people since last year in countries such as Guinea, Sierra Leone and Liberia. (Source: CNN.com - Health)
Source: CNN.com - Health - September 18, 2015 Category: Consumer Health News Source Type: news

Bavarian Nordic Receives Contract Valued At USD 9 Million From Janssen As Part Of Advanced Development Of Prime-Boost Ebola Vaccine Regimen
Bavarian Nordic A/S announced recently the award of a subcontract from Crucell Holland B.V., one of Janssen Pharmaceutical Companies of Johnson & Johnson, valued at USD 9 million. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - September 16, 2015 Category: Pharmaceuticals Source Type: news

Liberia: 'You Are Ambassadors of Prevail'
[New Republic] Throngs of Ebola survivors that have signed unto working with the Partnership on Research for Ebola Vaccine in Liberia (PREVAILIII) in the ongoing Ebola Natural History Study were Friday unleashed into communities to encourage other survivors into the Study, and told that they should regard themselves are ambassadors of PREVAIL. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 14, 2015 Category: African Health Source Type: news

Sierra Leone: As Four New Cases Recorded- Who Team Vaccinates Ebola Contacts
[Concord] As the country recorded four new Ebola cases in recent weeks, a World Health Organization (WHO) vaccination team from Guinea and Sierra Leone are hard at work vaccinating Ebola close contacts in the Kambia District. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 11, 2015 Category: African Health Source Type: news

Sex And Masturbation Could Put Ebola Recovery In Jeopardy
By Tom Miles GENEVA (Reuters) - Isolated flare-ups of Ebola may point to a higher risk of transmission via the semen of male survivors than previously thought, undermining hopes of ending West Africa's deadly outbreak by the end of the year. The World Health Organization's advice is that all male survivors should be tested three months after the onset of symptoms and then monthly until they know they have no risk of passing on the virus through their semen, Bruce Aylward, head of the WHO's Ebola response, told a news conference. But a forthcoming study in the New England Journal of Medicine, based on around 200 survivors, ...
Source: Science - The Huffington Post - September 9, 2015 Category: Science Source Type: news

Liberia: 20 Ebola Survivors Undergo Intensive Training
[New Republic] In continuation of efforts aim to further enhance its engagement with Ebola survivors across the country to motivate and encourage them into the ongoing Ebola Natural History Study, the Partnership on Research for Ebola Vaccine in Liberia (PREVAIL III) at the weekend embarked on an intensive training and capacity building of 120 Ebola Survivors. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 8, 2015 Category: African Health Source Type: news

Polio resurfaces in Mali from Ebola-hit Guinea: WHO
GENEVA (Reuters) - Cases of a crippling vaccine-derived polio virus could spread in Ebola-ravaged Guinea and in Mali after a Guinean toddler traveled to Mali and became the country's first polio case in more than four years, the World Health Organization said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - September 7, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

In Campaign To Prevent Ebola, A Vaccine For Apes Could Save Humans, Too
After the Ebola epidemic in West Africa, University of Cambridge researcher Peter Walsh has been developing an Ebola vaccine for wild apes, hoping to stop transmission of the deadly virus to humans.» E-Mail This (Source: NPR Health and Science)
Source: NPR Health and Science - September 6, 2015 Category: Consumer Health News Source Type: news

How EMS Can Be Prepared for Enterovirus D68 and Other Re-Emerging Infectious Diseases
Learning Objectives >>Learn about the possible causes of emergences and re-emergences of infectious diseases and how diseases spread. >>Understand when to have a high index of suspicion for enterovirus D68, which can present with many different signs and symptoms. >>Identify ways EMS systems can adapt during an outbreak to ensure provider safety while also still protecting and treating the community. Key Terms >>Emerging disease: A disease not previously recognized. >>Fomites: Any objects, including an EMS worker’s uniform, that can be contaminated by infectious pathogens and can play a ...
Source: JEMS Patient Care - September 4, 2015 Category: Emergency Medicine Authors: James F. Goss, MHA, MICP Tags: Infectious Diseases Patient Care Source Type: news